Trulieve Cannabis (NYSE:TRLV) CEO Kim Rivers Sells 136,811 Shares

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 136,811 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $8.76, for a total transaction of $1,198,464.36. Following the completion of the transaction, the chief executive officer directly owned 1,476,913 shares of the company’s stock, valued at $12,937,757.88. This represents a 8.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Price Performance

Trulieve Cannabis stock opened at $8.93 on Friday. Trulieve Cannabis Corp. has a twelve month low of $3.50 and a twelve month high of $13.28.

Wall Street Analysts Forecast Growth

TRLV has been the subject of a number of analyst reports. Zacks Research raised Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings started coverage on shares of Trulieve Cannabis in a report on Tuesday, June 16th. They set a “sell (d-)” rating for the company. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.